Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 65 matching records.
65 results — page 1 of 3
- Level BClinical TrialEurope PMC
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models
Clinical Trial on Cardiovascular Disease, published in Bioengineering (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Bioengineering (Basel) - Level DNarrative ReviewEurope PMC
Advances in nanomaterials for the diagnosis and treatment of ischemic heart disease
Narrative Review on Cardiovascular Disease, published in Discov Nano (2026) — summary generated from the PubMed abstract.
- 2026
Discov Nano - Level DNarrative ReviewPubMed
Epicardial patches for myocardial repair: circumventing barriers to heal ischemic heart tissue.
Narrative Review on Cardiovascular Disease, Scar, published in Trends Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Trends Biotechnol - Level BRandomized Controlled TrialPubMed
Adipose tissue-derived mesenchymal stromal cell therapy in nonischemic heart failure with reduced ejection fraction - ARIISE study design.
Randomized Controlled Trial on Cardiovascular Disease, Stroke Research, Immune Modulation, published in Future Cardiol (2026) — summary generated from the PubMed abstract.
- 2026
Future Cardiol - Level DNarrative ReviewEurope PMC
A comprehensive review of ischemic heart disease: pathophysiology, current treatments, natural products-based therapies, and nanotherapeutics
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Front Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Front Pharmacol - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev - Level ASystematic ReviewEurope PMC
Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease
Systematic Review on Cardiovascular Disease, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus7 citations - Level DAnimal StudyPubMed
L-arginine from elder human mesenchymal stem cells induces angiogenesis and enhances therapeutic effects on ischemic heart diseases.
Animal Study on Cardiovascular Disease, Chronic Wound, Scar, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level DNarrative ReviewEurope PMC
Exploring hiPSC-CM replacement therapy in ischemic hearts
Narrative Review on Cardiovascular Disease, published in Basic Res Cardiol (2025) — summary generated from the PubMed abstract.
- 2025
Basic Res Cardiol - Level ARandomized Controlled TrialPubMed
Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.
Randomized Controlled Trial with a reported sample of 214 on Cardiovascular Disease, published in Regen Med (2025) — summary generated from the PubMed abstract.
- 2025
- n = 214
Regen Med - Level DNarrative ReviewEurope PMC
Metabolic regulation for the treatment of ischemic heart disease with stem cells and extracellular vesicles
Narrative Review on Cardiovascular Disease, published in NPJ Cardiovasc Health (2025) — summary generated from the PubMed abstract.
- 2025
NPJ Cardiovasc Health3 citations - Level BClinical TrialPubMed
Application of adipose-derived stem cells in ischemic heart disease: theory, potency, and advantage.
Clinical Trial on Cardiovascular Disease, Immune Modulation, published in Front Cardiovasc Med (2024) — summary generated from the PubMed abstract.
- 2024
Front Cardiovasc Med12 citations - Level DNarrative ReviewEurope PMC
To Repair a Broken Heart: Stem Cells in Ischemic Heart Disease
Narrative Review on Cardiovascular Disease, published in Curr Issues Mol Biol (2024) — summary generated from the PubMed abstract.
- 2024
Curr Issues Mol Biol4 citations - Level DNarrative ReviewPubMed
Stem Cell Therapy against Ischemic Heart Disease.
Narrative Review on Cardiovascular Disease, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci14 citations - Level DNarrative ReviewEurope PMC
Nanomedicines as Guardians of the Heart: Unleashing the Power of Antioxidants to Alleviate Myocardial Ischemic Injury
Narrative Review on Cardiovascular Disease, published in Theranostics (2024) — summary generated from the PubMed abstract.
- 2024
Theranostics4 citations - Level ASystematic ReviewPubMed
Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: A Systematic Review.
Systematic Review on Cardiovascular Disease, published in Arq Bras Cardiol (2024) — summary generated from the PubMed abstract.
- 2024
Arq Bras Cardiol3 citations - Level DNarrative ReviewEurope PMC
Rebuilding the myocardial microenvironment to enhance mesenchymal stem cells-mediated regeneration in ischemic heart disease
Narrative Review on Cardiovascular Disease, published in Front Bioeng Biotechnol (2024) — summary generated from the PubMed abstract.
- 2024
Front Bioeng Biotechnol7 citations - Level DAnimal StudyPubMed
CSF2RB overexpression promotes the protective effects of mesenchymal stromal cells against ischemic heart injury.
Animal Study on Cardiovascular Disease, Stroke Research, published in Theranostics (2023) — summary generated from the PubMed abstract.
- 2023
Theranostics - Level DLaboratory StudyPubMed
Cardiac patches made of brown adipose-derived stem cell sheets and conductive electrospun nanofibers restore infarcted heart for ischemic myocardial infarction.
Laboratory Study on Cardiovascular Disease, published in Bioact Mater (2023) — summary generated from the PubMed abstract.
- 2023
Bioact Mater37 citations - Level BRandomized Controlled TrialPubMed
Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIEN
Randomized Controlled Trial with a reported sample of 15 on Cardiovascular Disease, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
- n = 15
Int J Mol Sci6 citations - Level BClinical TrialEurope PMC
Stem cells treatment in chronic ischemic heart disease: a narrative review
Clinical Trial with a reported sample of 1824 on Cardiovascular Disease, published in Am J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
- n = 1824
Am J Stem Cells3 citations - Level DNarrative ReviewEurope PMC
Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease
Narrative Review on Cardiovascular Disease, published in Stem Cells Int (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cells Int9 citations - Level DAnimal StudyPubMed
Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury.
Animal Study on Cardiovascular Disease, published in Adv Sci (Weinh) (2022) — summary generated from the PubMed abstract.
- 2022
Adv Sci (Weinh) - Level DNarrative ReviewPubMed
Therapeutic properties of stem cell-derived exosomes in ischemic heart disease.
Narrative Review on Cardiovascular Disease, published in Eur J Pharmacol (2022) — summary generated from the PubMed abstract.
- 2022
Eur J Pharmacol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406